Delivery of TLR7 agonist to monocytes and dendritic cells by DCIR targeted liposomes induces robust production of anti-cancer cytokines

TCB Klauber, JM Laursen, D Zucker, S Brix, SS Jensen… - Acta Biomaterialia, 2017 - Elsevier
Tumor immune escape is today recognized as an important cancer hallmark and is therefore
a major focus area in cancer therapy. Monocytes and dendritic cells (DCs), which are central …
被引用次数：45 相关文章

[引用][C] Delivery of TLR7 agonist to monocytes and dendritic cells by DCIR targeted liposomes induces robust production of anti-cancer cytokines

TCB Klauber, JM Laursen, D Zucker, S Brix… - Acta …, 2017 - hero.epa.gov
Delivery of TLR7 agonist to monocytes and dendritic cells by DCIR targeted liposomes
induces robust production of anti-cancer cytokines | Health & Environmental Research Online …
[PDF] dtu.dk

[PDF][PDF] Delivery of TLR7 agonist to monocytes and dendritic cells by DCIR targeted liposomes induces robust production of anti-cancer cytokines.

TCB Klauber, JM Laursen, D Zucker… - The 43rd Annual …, 2016 - orbit.dtu.dk
Conclusions 1. Kalinski, P. et al. Natural killer-dendritic cell cross-talk in cancer
immunotherapy Expert Opin. Biol. Ther. 5, 1303–15 (2005). 2. Monjazeb, AM et al …
[PDF] core.ac.uk

[PDF][PDF] Delivery of TLR7 agonist to monocytes and dendritic cells by DCIR targeted liposomes induces robust production of anti-cancer cytokines

TCB Klaubera, JM Laursenb, D Zuckerb, S Brixa… - core.ac.uk
Conclusions 1. Kalinski, P. et al. Natural killer-dendritic cell cross-talk in cancer
immunotherapy Expert Opin. Biol. Ther. 5, 1303–15 (2005). 2. Monjazeb, AM et al …

Delivery of TLR7 agonist to monocytes and dendritic cells by DCIR targeted liposomes induces robust production of anti-cancer cytokines

TCB Klauber, JM Laursen, D Zucker… - Acta …, 2017 - pubmed.ncbi.nlm.nih.gov
Tumor immune escape is today recognized as an important cancer hallmark and is therefore
a major focus area in cancer therapy. Monocytes and dendritic cells (DCs), which are central …

Delivery of TLR7 agonist to monocytes and dendritic cells by DCIR targeted liposomes induces robust production of anti-cancer cytokines

TCB Klauber, JM Laursen, D Zucker, S Brix… - Acta Biomaterialia, 2017 - infona.pl
Tumor immune escape is today recognized as an important cancer hallmark and is therefore
a major focus area in cancer therapy. Monocytes and dendritic cells (DCs), which are central …

[引用][C] Delivery of TLR7 agonist to monocytes and dendritic cells by DCIR targeted liposomes induces robust production of anti-cancer cytokines

TCB Klauber, JM Laursen, D Zucker, S Brix… - Acta …, 2017 - cir.nii.ac.jp
Delivery of TLR7 agonist to monocytes and dendritic cells by DCIR targeted liposomes induces
robust production of anti-cancer cytokines | CiNii Research CiNii 国立情報学研究所 学術情報 …

Delivery of TLR7 agonist to monocytes and dendritic cells by DCIR targeted liposomes induces robust production of anti-cancer cytokines.

TCB Klauber, JM Laursen, D Zucker, S Brix… - Acta …, 2017 - europepmc.org
Tumor immune escape is today recognized as an important cancer hallmark and is therefore
a major focus area in cancer therapy. Monocytes and dendritic cells (DCs), which are central …

Delivery of TLR7 agonist to monocytes and dendritic cells by DCIR targeted liposomes induces robust production of anti-cancer cytokines

TCB Klauber, JM Laursen, D Zucker, SB Pedersen… - Acta …, 2017 - orbit.dtu.dk
Tumor immune escape is today recognized as an important cancer hallmark and is therefore
a major focus area in cancer therapy. Monocytes and dendritic cells (DCs), which are central …